盟科药业-U
(688373)
| 流通市值：15.02亿 | | | 总市值：28.57亿 |
| 流通股本：3.44亿 | | | 总股本：6.55亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 90,776,385.24 | 68,272,315.43 | 42,110,171.77 | 17,276,928.37 |
| 营业收入 | 90,776,385.24 | 68,272,315.43 | 42,110,171.77 | 17,276,928.37 |
| 二、营业总成本 | 538,482,151.17 | 335,652,567.97 | 184,852,221.21 | 83,381,235.35 |
| 营业成本 | 16,695,863.64 | 12,503,164.6 | 7,865,572.56 | 3,377,059.52 |
| 税金及附加 | 296,271.78 | 162,454.61 | 119,441.11 | 58,980.17 |
| 销售费用 | 107,406,779.7 | 69,158,041.5 | 44,729,290.84 | 15,388,056.12 |
| 管理费用 | 61,165,618.06 | 43,340,308.88 | 30,085,060.67 | 16,997,330.94 |
| 研发费用 | 344,861,801.85 | 202,949,875.3 | 96,098,409.76 | 43,468,902.65 |
| 财务费用 | 8,055,816.14 | 7,538,723.08 | 5,954,446.27 | 4,090,905.95 |
| 其中:利息费用 | 10,135,035.97 | 7,390,136.51 | 5,332,220.54 | 1,191,464.94 |
| 其中:利息收入 | 2,185,334.04 | 1,486,777.58 | 894,815.03 | 449,073.03 |
| 加:公允价值变动收益 | 33,343,844.05 | 27,132,206.65 | 21,489,403.45 | 9,733,847.47 |
| 资产处置收益 | 1,459.62 | 1,459.62 | 1,459.62 | - |
| 信用减值损失(新) | -328,022.54 | -174,794.53 | 114,058.34 | 9,780.94 |
| 其他收益 | 3,784,662.76 | 198,462.76 | 198,462.76 | 198,462.76 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -410,903,822.04 | -240,222,918.04 | -120,938,665.27 | -56,162,215.81 |
| 减:营业外支出 | 4,249,336.21 | 4,230,089.2 | 4,178,408.23 | - |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -415,153,158.25 | -244,453,007.24 | -125,117,073.5 | -56,162,215.81 |
| 减:所得税费用 | 5,971,294.4 | 5,611.86 | 5,543.3 | - |
| 六、净利润 | -421,124,452.65 | -244,458,619.1 | -125,122,616.8 | -56,162,215.81 |
| 持续经营净利润 | -421,124,452.65 | -244,458,619.1 | -125,122,616.8 | -56,162,215.81 |
| 归属于母公司股东的净利润 | -421,124,452.65 | -244,458,619.1 | -125,122,616.8 | -56,162,215.81 |
| (一)基本每股收益 | -0.64 | -0.37 | -0.19 | -0.09 |
| (二)稀释每股收益 | -0.64 | -0.37 | -0.19 | -0.09 |
| 八、其他综合收益 | 3,714,041.65 | 10,842,714.39 | 12,150,057.27 | -4,374,668.27 |
| 归属于母公司股东的其他综合收益 | 3,714,041.65 | 10,842,714.39 | 12,150,057.27 | -4,374,668.27 |
| 九、综合收益总额 | -417,410,411 | -233,615,904.71 | -112,972,559.53 | -60,536,884.08 |
| 归属于母公司股东的综合收益总额 | -417,410,411 | -233,615,904.71 | -112,972,559.53 | -60,536,884.08 |
| 公告日期 | 2024-03-28 | 2023-10-27 | 2023-08-26 | 2023-04-21 |
| 审计意见(境内) | 标准无保留意见 | | | |